Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Probiomed has been acquired by Sanfer
The shareholders of Probiomed S.A. de C.V. have sold the company to Laboratorios Sanfer.
Learn more
Jan De Backer
CEO, Fluidda NV
Read more
Strategic steps, global reach: mid-market M&A in Q1
QUARTERLY M&A ACTIVITY: In Q1 2026, Oaklins' clients completed 44 transactions across sectors and regions, highlighting continued cross-border activity and a focus on growth, capital and strategic expansion.
Learn more